Analyst Ratings February 4, 2026

Wells Fargo raises Marathon Petroleum target to $217 after robust Q4 results

Analyst keeps Overweight as refining outperformance and share repurchases underpin capital return profile

By Nina Shah MPC
Wells Fargo raises Marathon Petroleum target to $217 after robust Q4 results
MPC

Wells Fargo increased its 12-month price target for Marathon Petroleum (MPC) to $217 from $213 and retained an Overweight rating after Marathon reported stronger-than-expected fourth-quarter 2025 results. The move reflects a combination of an EPS beat, unexpectedly high refining EBITDA and continued shareholder returns through buybacks and distributions.

Key Points

  • Wells Fargo raised its price target on Marathon Petroleum to $217 from $213 and maintained an Overweight rating, implying about 16% upside from the then-current share price.
  • Marathon beat expectations in Q4 2025 with adjusted EPS of $4.07, outpacing consensus and Wells Fargo forecasts; refining EBITDA of $1,997 million materially exceeded analyst expectations.
  • Management continued shareholder-friendly actions: $1 billion of share repurchases in the quarter, MPLX guidance for 12.5% distribution growth over the next two years, and a dividend paid for 16 consecutive years (yield 2.13%).

Wells Fargo updated its outlook for Marathon Petroleum (NYSE: MPC) on Wednesday, raising the firms price target to $217.00 from $213.00 while maintaining an Overweight recommendation. The revised target implies roughly 16% potential upside from Marathons then-current share price of $187.58, and the stock was trading near its 52-week high of $202.29.

The banks revision follows Marathons fourth-quarter 2025 earnings release. The company reported adjusted earnings per share of $4.07 for the quarter, a result that exceeded both consensus estimates of $2.72 and Wells Fargos internal forecast of $2.53. The quarter also compared favorably to another published projection of $3.01, with the $4.07 EPS representing a 35.22% beat relative to that figure. On a trailing twelve-month basis, Marathon reported basic EPS of $13.27, which situates the company at a reported price-to-earnings ratio of 20.63.

Operationally, the refining business was a major contributor to the quarters upside. Marathons refining segment produced EBITDA of $1,997 million, well ahead of Wells Fargos projection of $1,229 million. The firm attributed the outperformance to stronger throughput, sequentially improved capture rates and lower operating expenses. Turnaround costs in the period were recorded at $409 million, coming in below both analyst estimates and company guidance of $419 million and $420 million, respectively.

Despite these strengths, InvestingPro data cited in company analysis highlights relatively weak gross profit margins of 10.48% for Marathon, a metric that stands in contrast to the quarters positive EBITDA dynamics.

Results across other segments were mixed. Marathons midstream operating income was reported at $1.3 billion, which fell short of Wells Fargos expectation of $1.5 billion. The Renewable Diesel business posted a $48 million loss in the quarter, a somewhat smaller shortfall than Wells Fargos estimated loss of $55 million.

Capital allocation actions remained a focal point for management. Marathon repurchased $1 billion of shares in the fourth quarter, a level consistent with analyst expectations, and management commentary pointed to MPLXs intent to sustain 12.5% distribution growth over the next two years. Marathon also flagged an acceleration of growth capital expenditures beginning in 2026, which the company said will support its return-of-capital objectives.

InvestingPro materials referenced in the companys research package note that management has been active on buybacks while preserving a dividend that has been paid for 16 consecutive years; the dividend yield at the time was 2.13%. Additional analysis and Pro Research content were noted as available on InvestingPro for subscribers seeking a deeper view of Marathons capital allocation strategy.

On top of Wells Fargos update, other sell-side activity followed the earnings release. TD Cowen raised its price target on Marathon Petroleum to $198 from $183 and reiterated a Buy rating, with the firms upgrade tied to refining gross margins aligning with historical capture rates. Marathon reported revenue of $33.42 billion for the quarter versus an anticipated $32.86 billion, producing a revenue surprise of 1.7%.

Overall, the combination of an EPS beat, stronger-than-expected refining EBITDA and a continued focus on share repurchases and distributions informed Wells Fargos decision to lift its price target and sustain an Overweight stance. InvestingPro valuation indicators were cited as suggesting Marathon appears slightly undervalued on a Fair Value basis, according to the same data set.


Contextual note: The article reports the figures and analyst actions as presented in company and analyst disclosures. Where multiple analyst estimates are noted, each figure is reported as originally provided.

Risks

  • Relatively weak gross profit margins of 10.48% could pressure profitability despite strong EBITDA performance - this primarily affects the refining and downstream energy sectors.
  • Midstream operating income underperformed expectations ($1.3 billion reported versus $1.5 billion estimated), signaling potential volatility in midstream earnings that could affect energy infrastructure investors.
  • The Renewable Diesel business posted a $48 million loss for the quarter, indicating near-term headwinds in that segment that could temper returns from renewable fuels investments.

More from Analyst Ratings

Mizuho trims AMD price target to $275, cites higher AI-related spending Feb 4, 2026 Needham Cuts Varonis Target to $30, Flags SaaS Transition as Key Uncertainty Feb 4, 2026 Northland Keeps Outperform on AMD, Sees Strong AI Momentum but Flags Long-Term Caution Feb 4, 2026 Mizuho Lifts Emerson Price Target to $173 Citing Strong Order Momentum and Project Wins Feb 4, 2026 Needham Cuts Super Micro Computer Price Target to $40 While Keeping Buy Rating Feb 4, 2026